Linperlisib
Linperlisib (YY-20394) is a potent, orally bioavailable and selective inhibitor of PI3Kδ extracted from patent WO 2015055071 A1, compound 10; has an IC50 of 6.4 nM[1].
Product Specifications
CAS Number
1702816-75-8
Product Name Alternative
YY-20394
UNSPSC
12352005
Target
PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/PI3K_delta_-IN-2.html
Purity
98.91
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CS(=O)(NC1=CC(C2=C3C=C(F)C=C(CN4CCC(C(C)(O)C)CC4)C3=NC(N5CCOCC5)=N2)=CN=C1OC)=O
Molecular Formula
C28H37FN6O5S
Molecular Weight
588.69
References & Citations
[1]WO 2015055071 A1
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 4
Isoform
PI3Kδ
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
25548121 3x 1.0µg DNA
KIAA0564 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 
PSA-HF244-25ug 25 µg
FITC-Labeled Human PSMA / FOLH1 Protein, His Tag
Sign In for Pricing
View Details 
47354126 3x 1.0µg DNA
TPD52L3 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Sign In for Pricing
View Details